Clinical trial
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency: the PERT-AP Trial
NCT06477159 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency: the PERT-AP Trial
- Lead sponsor
- Ohio State University
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 1, 2024
- Completion date
- December 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.